Grania Brigden's research while affiliated with International Union Against Tuberculosis and Lung Disease (The Union) and other places
What is this page?
This page lists the scientific contributions of an author, who either does not have a ResearchGate profile, or has not yet added these contributions to their profile.
It was automatically created by ResearchGate to create a record of this author's body of work. We create such pages to advance our goal of creating and maintaining the most comprehensive scientific repository possible. In doing so, we process publicly available (personal) data relating to the author as a member of the scientific community.
If you're a ResearchGate member, you can follow this page to keep up with this author's work.
If you are this author, and you don't want us to display this page anymore, please let us know.
It was automatically created by ResearchGate to create a record of this author's body of work. We create such pages to advance our goal of creating and maintaining the most comprehensive scientific repository possible. In doing so, we process publicly available (personal) data relating to the author as a member of the scientific community.
If you're a ResearchGate member, you can follow this page to keep up with this author's work.
If you are this author, and you don't want us to display this page anymore, please let us know.
Publications (14)
Introduction
Tobacco smoking is a significant risk factor for developing tuberculosis (TB), contributing to diagnostic delays, poor treatment outcomes and an increased risk of death and relapse. The World Health Organization (WHO) has reported that TB rates could decline by as much as 20% if smoking were eliminated. Tobacco smoking was a risk facto...
Objectives
To determine tuberculosis (TB) recurrence in previously successfully treated patients in routine program setting and baseline characteristics associated with TB recurrence.
Methods
A prospective longitudinal study in Jiangxi Province, China. Patients, ≥14 years old, were consecutively registered and were followed-up for 7-year to assess...
Objective
To identify any medical or public health rationale for claims that the time to act is now.
Design
Pseudo-systematic review.
Data sources
PubMed.
Study selection
Studies that included the claim “time is now” in the title, with or without exclamation marks. No language or date restriction was applied.
Results
512 articles were included...
Objective:
Tuberculosis (TB) treatment success rates are high in China, but there are still a considerable number of cases who have unfavourable treatment outcomes (UTO). We aimed to determine the pro-portion of TB patients with UTO and to assess whether baseline characteristics that included glycaemic status [normal fasting blood glucose (FBG), t...
h2>SUMMARY
The international community has committed to end the tuberculosis (TB) epidemic by 2030. To facilitate the meeting of the global incidence and mortality indicators set by the World Health Organization's End TB Strategy, the Stop TB Partnership launched the three 90-(90)-90 diagnostic and treatment targets in 2014. In this paper, we...
• The World Health Organization (WHO) plays an important role in setting global norms and standards with a focus on public health and publishes international guidelines regularly to support Member States, particularly ministries of health, in the provision of the highest standard of healthcare. • Over the last 5 years, multiple advances in diagnosi...
Citations
... On the other hand, the female sex was not a predictor of TB recurrence, implying that other vari- ables, such as smoking, alcohol consumption, and chronic obstructive pulmonary disease (COPD), could be confounding factors. Previous research has revealed that smoking, drinking, and being underweight are risk factors for TB recurrence [29][30][31][32] . However, we lacked information on these variables. ...
... There is growing evidence of an increased probability of COVID-19 in people with diabetes that may lead to hospitalization, organ failure, and premature mortality. 30 In TB patients and COVID-19 patients, the combination of malnutrition and low BMI is a major risk factor for early mortality. 31 ...
... Given the current burden of post-TB disease, morbidity and mortality, patients with TB would merit being assessed for general health status at the end of anti-TB treatment. We have previously argued that an end-of-treatment assessment needs to be carried out within the context of a national TB program (NTP), using a simple check list that documents on going symptoms, co-morbidities, social determinants and lung function, with appropriate actions taken if disability is identified [7,8]. However, most NTPs currently only focus on diagnosis and treatment. ...
... TB epidemiology in the Asia Pacific Region indicates a higher risk for males [67], but women often carry the burden of TB disease differently-through being the unpaid caretakers, having their healthcare deprioritized for the benefit of their male counterparts, and carrying a heavy burden of stigma associated with the disease [68]. In addition, in many high burden TB settings women also suffer from high rates of gender-based violence, HIV and other co-occurring biosocial phenomena [69,70]. ...
... If a pathological part of the body yields no symptoms, is it medically real? U.S. medicine prides itself on swift action (Ford, et al., 2020;, but when that's not possible, the path falls apart. Chronic-illness patients suffer from the uncertainty (Charmaz, 1983). ...
... In response to the growing evidence for a high burden of morbidity and mortality amongst TB-survivors, there have been calls from TB-affected groups, healthcare providers, and researchers for the development of clinical guidelines and programmatic standards for post-TB patient care [15][16][17][18]. However, there remain many barriers to implementation. ...
... This confirms the findings of a study on early access to BDQ performed in 2015, where lack of access to companion drugs was the most commonly reported countrylevel barrier [8]. Guaranteeing adequate procurement of affordable RR-TB drugs is thus essential to translate new policies and guidelines into practice and to accelerate the adoption of new advancements in TB care [53,54]. ...
... Inclusion of OR in the national strategic plan is important, because many donors including the Global Fund against AIDS, Tuberculosis and Malaria, do not fund interventions which are not a part of the national strategic plans. 19 Dedicated budgets will be required for paying salaries of personnel working on OR and their trainings, protocol development and ethics review, data collection (which may involve hiring additional people, travel, telecommunication expenses, hotel stay outside duty stations and per diem), data entry and analysis (which may require hiring of data entry operators or using computers and internet), dissemination of research findings nationally and internationally in conferences and publication in open access journals. All these processes cost money and these need to be budgeted. ...